| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sven Jarius, Klemens Ruprecht, Ingo Kleiter, Nadja Borisow, Nasrin Asgari, Kalliopi Pitarokoili, Florence Pache, Oliver Stich, Lena-Alexandra Beume, Martin W Hümmert, Marius Ringelstein, Corinna Trebst, Alexander Winkelmann, Alexander Schwarz, Mathias Buttmann, Hanna Zimmermann, Joseph Kuchling, Diego Franciotta, Marco Capobianco, Eberhard Siebert, Carsten Lukas, Mirjam Korporal-Kuhnke, Jürgen Haas, Kai Fechner, Alexander U Brandt, Kathrin Schanda, Orhan Aktas, Friedemann Paul, Markus Reindl, Brigitte Wildeman. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Journal of neuroinflammation. vol 13. issue 1. 2017-10-10. PMID:27793206. |
a subset of patients with neuromyelitis optica spectrum disorders (nmosd) has been shown to be seropositive for myelin oligodendrocyte glycoprotein antibodies (mog-igg). |
2017-10-10 |
2023-08-13 |
Not clear |
| Florence Pache, Hanna Zimmermann, Janine Mikolajczak, Sophie Schumacher, Anna Lacheta, Frederike C Oertel, Judith Bellmann-Strobl, Sven Jarius, Brigitte Wildemann, Markus Reindl, Amy Waldman, Kerstin Soelberg, Nasrin Asgari, Marius Ringelstein, Orhan Aktas, Nikolai Gross, Mathias Buttmann, Thomas Ach, Klemens Ruprecht, Friedemann Paul, Alexander U Brand. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. Journal of neuroinflammation. vol 13. issue 1. 2017-10-06. PMID:27802824. |
antibodies against myelin oligodendrocyte glycoprotein (mog-igg) have been reported in patients with aquaporin-4 antibody (aqp4-igg)-negative neuromyelitis optica spectrum disorders (nmosd). |
2017-10-06 |
2023-08-13 |
Not clear |
| İpek Polat, Uluç Yiş, Pakize Karaoğlu, Muge Ayanoğlu, Tülay Öztürk, Handan Güleryüz, Semra Hız Kuru. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case. Pediatrics. vol 137. issue 5. 2017-05-31. PMID:27244783. |
myelin oligodendrocyte glycoprotein (mog) is a candidate target antigen in demyelinating central nervous system diseases, including acute disseminated encephalomyelitis (adem), neuromyelitis optica, and multiple sclerosis. |
2017-05-31 |
2023-08-13 |
human |
| Christian Lechner, Matthias Baumann, Eva-Maria Hennes, Kathrin Schanda, Klaus Marquard, Michael Karenfort, Steffen Leiz, Daniela Pohl, Sunita Venkateswaran, Martin Pritsch, Johannes Koch, Mareike Schimmel, Martin Häusler, Andrea Klein, Astrid Blaschek, Charlotte Thiels, Thomas Lücke, Ursula Gruber-Sedlmayr, Barbara Kornek, Andreas Hahn, Frank Leypoldt, Torsten Sandrieser, Helge Gallwitz, Johannes Stoffels, Christoph Korenke, Markus Reindl, Kevin Rostás. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. Journal of neurology, neurosurgery, and psychiatry. vol 87. issue 8. 2017-05-25. PMID:26645082. |
to determine the frequency and clinical-radiological associations of antibodies to myelin oligodendrocyte glycoprotein (mog) and aquaporin-4 (aqp4) in children presenting with neuromyelitis optica (nmo) and limited forms. |
2017-05-25 |
2023-08-13 |
Not clear |
| Yoshitsugu Nakamura, Hideto Nakajima, Hiroki Tani, Takafumi Hosokawa, Shimon Ishida, Fumiharu Kimura, Kimihiko Kaneko, Toshiyuki Takahashi, Ichiro Nakashim. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report. BMC neurology. vol 17. issue 1. 2017-05-16. PMID:28420330. |
anti-myelin oligodendrocyte glycoprotein (mog) antibodies are detected in various demyelinating diseases, such as pediatric acute disseminated encephalomyelitis (adem), recurrent optic neuritis, and aquaporin-4 antibody-seronegative neuromyelitis optica spectrum disorder. |
2017-05-16 |
2023-08-13 |
Not clear |
| Victoria Young, Gerardine Quaghebeu. Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders. Seminars in ultrasound, CT, and MR. vol 37. issue 5. 2017-04-10. PMID:27616312. |
the picture is more complicated with the expansion of the description to involve neuromyelitis optica spectrum disorders, new antibodies such as myelin oligodendrocyte glycoprotein and the inclusion of an antibody-negative variant. |
2017-04-10 |
2023-08-13 |
Not clear |
| Masami Tanak. The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod. Rinsho shinkeigaku = Clinical neurology. vol 56. issue 4. 2017-03-23. PMID:27010095. |
i compared the risk of developing herpes zoster between 32 ms patients treated with fingolimod (fty-ms) and 45 patients, including those with neuromyelitis optica spectrum disorder, horizontal hemianopsia without anti-aquaporin-4 antibodies, and myelitis with anti-myelin oligodendrocyte glycoprotein antibodies, treated with tacrolimus (tcr-nmo). |
2017-03-23 |
2023-08-13 |
Not clear |
| Axel Petzold, Sui Wong, Gordon T Plan. Autoimmunity in visual loss. Handbook of clinical neurology. vol 133. 2017-02-09. PMID:27112687. |
previously an enigmatic partner to multiple sclerosis, neuromyelitis optica is now established to be autoimmune and two antibodies - to aquaporin4 and to myelin oligodendrocyte glycoprotein - have been implicated in the pathogenesis. |
2017-02-09 |
2023-08-13 |
Not clear |
| Ángela Domingo-Santos, María Sepúlveda, Michele Matarazzo, Patricia Calleja-Castaño, Ana Ramos-González, Albert Saiz, Julián Benito-Leó. Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27454390. |
intravenous immunoglobulin therapy in a patient with anti-myelin oligodendrocyte glycoprotein-seropositive neuromyelitis optica. |
2017-01-23 |
2023-08-13 |
Not clear |
| Melania Spadaro, Edgar Mein. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases. Methods in molecular biology (Clifton, N.J.). vol 1304. 2016-05-05. PMID:25814289. |
autoantibodies against myelin oligodendrocyte glycoprotein (mog) occur in a proportion of patients with different inflammatory demyelinating diseases of the central nervous system, such as childhood multiple sclerosis (ms), acute disseminated encephalomyelitis (adem), and neuromyelitis optica spectrum disorders (nmosd). |
2016-05-05 |
2023-08-13 |
Not clear |
| Romana Höftberger, María Sepulveda, Thaís Armangue, Yolanda Blanco, Kevin Rostásy, Alvaro Cobo Calvo, Javier Olascoaga, Lluís Ramió-Torrentà, Markus Reindl, Julián Benito-León, Bonaventura Casanova, Georgina Arrambide, Lidia Sabater, Francesc Graus, Josep Dalmau, Albert Sai. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Multiple sclerosis (Houndmills, Basingstoke, England). vol 21. issue 7. 2016-03-29. PMID:25344373. |
we aimed to report the frequency and implications of antibodies to myelin oligodendrocyte glycoprotein (mog-ab) in adults with demyelinating syndromes suspicious for neuromyelitis optica (nmo). |
2016-03-29 |
2023-08-13 |
Not clear |
| Anne-Katrin Pröbstel, Gabrielle Rudolf, Klaus Dornmair, Nicolas Collongues, Jean-Baptiste Chanson, Nicholas S R Sanderson, Raija L P Lindberg, Ludwig Kappos, Jérôme de Seze, Tobias Derfus. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Journal of neuroinflammation. vol 12. 2016-03-07. PMID:25889963. |
antibodies against myelin oligodendrocyte glycoprotein (mog) have been identified in a subgroup of pediatric patients with inflammatory demyelinating disease of the central nervous system (cns) and in some patients with neuromyelitis optica spectrum disorder (nmosd). |
2016-03-07 |
2023-08-13 |
Not clear |
| Lukmanee Tradtrantip, Nithi Asavapanumas, Puay-Wah Phuan, A S Verkma. Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model. PloS one. vol 9. issue 9. 2015-12-08. PMID:25191939. |
neuromyelitis optica (nmo) is an autoimmune demyelinating disease of the central nervous system in which binding of anti-aquaporin-4 (aqp4) autoantibodies (nmo-igg) to astrocytes causes complement-dependent cytotoxicity (cdc) and inflammation resulting in oligodendrocyte and neuronal injury. |
2015-12-08 |
2023-08-13 |
human |
| Samira Saadoun, Patrick Waters, Gregory P Owens, Jeffrey L Bennett, Angela Vincent, Marios C Papadopoulo. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta neuropathologica communications. vol 2. 2014-12-08. PMID:24685353. |
antibodies against myelin oligodendrocyte glycoprotein (mog-igg) are present in some neuromyelitis optica patients who lack antibodies against aquaporin-4 (aqp4-igg). |
2014-12-08 |
2023-08-12 |
mouse |
| Mark Woodhall, Arzu Çoban, Patrick Waters, Esme Ekizoğlu, Murat Kürtüncü, Erkingul Shugaiv, Recai Türkoğlu, Gulsen Akman-Demir, Mefkure Eraksoy, Angela Vincent, Erdem Tüzü. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica. Journal of the neurological sciences. vol 335. issue 1-2. 2014-07-07. PMID:24045088. |
glycine receptor and myelin oligodendrocyte glycoprotein antibodies in turkish patients with neuromyelitis optica. |
2014-07-07 |
2023-08-12 |
Not clear |
| Kevin Rostasy, Markus Reind. Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in children. Neuropediatrics. vol 44. issue 6. 2014-07-01. PMID:24166146. |
the recent detection of aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) autoantibodies in acquired inflammatory demyelinating diseases, such as neuromyelitis optica, or acute disseminated encephalomyelitis, and multiple sclerosis, in children strongly indicates that b-cell-dependent mechanisms contribute to the pathogenesis. |
2014-07-01 |
2023-08-12 |
Not clear |
| Cecile Delarasse, Paul Smith, David Baker, Sandra Amo. Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunology. vol 140. issue 4. 2014-04-18. PMID:23876060. |
myelin oligodendrocyte glycoprotein (mog), a minor protein of the central nervous system myelin, is recognized as a potential target in multiple sclerosis and neuromyelitis optica. |
2014-04-18 |
2023-08-12 |
mouse |
| Douglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto, Patrick J Waters, Frederico M de Haidar Jorge, Toshiyuki Takahashi, Ichiro Nakashima, Samira Luisa Apostolos-Pereira, Natalia Talim, Renata Faria Simm, Angelina Maria Martins Lino, Tatsuro Misu, Maria Isabel Leite, Masashi Aoki, Kazuo Fujihar. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. vol 82. issue 6. 2014-04-01. PMID:24415568. |
to evaluate clinical features among patients with neuromyelitis optica spectrum disorders (nmosd) who have myelin oligodendrocyte glycoprotein (mog) antibodies, aquaporin-4 (aqp4) antibodies, or seronegativity for both antibodies. |
2014-04-01 |
2023-08-12 |
Not clear |
| K Rostásy, S Mader, E M Hennes, K Schanda, V Gredler, A Guenther, A Blaschek, C Korenke, M Pritsch, D Pohl, O Maier, G Kuchukhidze, M Brunner-Krainz, T Berger, M Reind. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 19. issue 8. 2014-02-28. PMID:23257621. |
persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. |
2014-02-28 |
2023-08-12 |
Not clear |
| K Rostásy, S Mader, E M Hennes, K Schanda, V Gredler, A Guenther, A Blaschek, C Korenke, M Pritsch, D Pohl, O Maier, G Kuchukhidze, M Brunner-Krainz, T Berger, M Reind. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 19. issue 8. 2014-02-28. PMID:23257621. |
recently we showed that antibodies to myelin oligodendrocyte glycoprotein (mog) can be found in aquaporin-4 (aqp4)-immunoglobulin (igg) seronegative pediatric and adult patients with definite and high-risk neuromyelitis optica (nmo). |
2014-02-28 |
2023-08-12 |
Not clear |